Lack of Contribution of p66shc and Its Mitochondrial Translocation to Ischemia-Reperfusion Injury and Cardioprotection by Ischemic Preconditioning

被引:21
|
作者
Boengler, Kerstin [1 ]
Bencsik, Peter [2 ,3 ]
Paloczi, Janos [2 ,3 ]
Kiss, Krisztina [2 ,3 ]
Pipicz, Marton [2 ,3 ]
Pipis, Judit [2 ]
Ferdinandy, Peter [2 ,3 ,4 ]
Schluter, Klaus-Dieter [1 ]
Schulz, Rainer [1 ]
机构
[1] Justus Liebig Univ, Physiol Inst, Giessen, Germany
[2] Pharmahungary Grp, Szeged, Hungary
[3] Univ Szeged, Dept Biochem, Cardiovasc Res Grp, Szeged, Hungary
[4] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, Budapest, Hungary
来源
FRONTIERS IN PHYSIOLOGY | 2017年 / 8卷
关键词
ischemia/reperfusion; ischemic preconditioning; reactive oxygen species; mitochondria; p66shc; ISCHAEMIA/REPERFUSION BRAIN-INJURY; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; RADICAL GENERATION; GENETIC DELETION; LIFE-SPAN; P66(SHC); DYSFUNCTION; HEART; METABOLISM;
D O I
10.3389/fphys.2017.00733
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Whereas high amounts of reactive oxygen species (ROS) contribute to cardiac damage following ischemia and reperfusion (IR), low amounts function as trigger molecules in the cardioprotection by ischemic preconditioning (IPC). The mitochondria' translocation and contribution of the hydrogen peroxide-generating protein p66shc in the cardioprotection by IPC is unclear yet. In the present study, we investigated the mitochondria' translocation of p66shc, addressed the impact of p66shc on ROS formation after IR, and characterized the role of p66shc in IR injury per se and in the cardioprotection by IPC. The amount of p66shc in subsarcolemmal (SSM) and interfibrillar mitochondria (IFM) isolated from wildtype mouse left ventricles (LV) was determined after 40 min normoxic perfusion and after 30 min ischemia and 10 min reperfusion without and with IPC. The p66shc content in SSM (in % of normoxic controls, n = 5) was 174 +/- 16% (n = 6, p < 0.05) after IR, and was reduced to 128 +/- 13% after IPC (n = 6, p = ns). In IFM, the amount of p66shc remained unchanged (IR: 81 +/- 7%, n = 6; IPC: 110 +/- 5%, n = 6, p = ns). IR induced an increase in ROS formation in SSM and IFM isolated from mouse wildtype LV, which was more pronounced in SSM than in IFM (1.18 +/- 0.18 vs. 0.81 +/- 0.16, n = 6, p < 0.05). In mitochondria from p66shc-knockout mice (p66shc-KO), the increase in ROS formation by IR was not different between SSM and IFM (0.90 +/- 0.11 vs. 0.73 +/- 0.08, n = 6, p = ns). Infarct size (in % of the left ventricle) was 51.7 +/- 2.9% in wildtype and 59.7 +/- 3.8% in p66shc-KO hearts in vitro and was significantly reduced to 35.8 +/- 4.4% (wildtype) and 34.7 +/- 5.6% (p66shc-KO) by IPC, respectively. In vivo, infarct size was 57.8 +/- 2.9% following IR (n = 9) and was reduced to 40.3 +/- 3.5% by IPC (n = 11, p < 0.05) in wildtype mice. In p66shc-knockout mice, infarct sizes were similar to those measured in wildtype animals (IR: 56.2 +/- 4.3%, n = 11; IPC: 42.1 +/- 3.9%, n = 13, p < 0.05). Taken together, the mitochondria' translocation of p66shc following IR and IPC differs between mitochondrial populations. However, similar infarct sizes after IR and preserved infarct size reductions by IPC in p66shc-KO mice suggest that p66shc-derived ROS are not involved in the cardioprotection by IPC nor do they contribute to IR injury per se.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Tetrandrine Protects Hearts Against Ischemia-Reperfusion Injury Via The Inhibition of p66Shc Phosphorylation And Mitochondrial Translocation
    He, Kathleen
    Shang, Hongming
    Balschi, James
    McGowan, Francis, Jr.
    He, Huamei
    FASEB JOURNAL, 2021, 35
  • [2] P66SHC A NOVEL TARGET IN THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY (IRI)
    Khalid, S.
    Furlan, T.
    Guenther, J.
    Drasche, A.
    Hermann, M.
    Troppmair, J.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 12 - 12
  • [3] P66SHC: A DRUGGABLE TARGET IN THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY (IRI)?
    Khalid, S.
    Haller, M.
    Kremser, L.
    Fresser, F.
    Furlan, T.
    Hermann, M.
    Guenther, J.
    Drasche, A.
    Leitges, M.
    Giorgio, M.
    Baier, G.
    Lindner, H.
    Troppmair, J.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 13
  • [4] P66SHC: A DRUGGABLE TARGET IN THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY (IRI)?
    Khalid, S.
    Haller, M.
    Kremser, L.
    Fresser, F.
    Furlan, T.
    Hermann, M.
    Guenther, J.
    Drasche, A.
    Leitges, M.
    Giorgio, M.
    Baier, G.
    Lindner, H.
    Troppmair, J.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 5 - 5
  • [5] P66SHC: A DRUGGABLE TARGET IN THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY (IRI)?
    Khalid, Sana
    Troppmair, Jakob
    TRANSPLANT INTERNATIONAL, 2017, 30 : 295 - 296
  • [6] Activation of p66shc in the heart subjected to ischemia/reperfusion injury
    Xiong, Hui
    McGowan, Francis X., Jr.
    He, Huamei
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [7] P66Shc Signaling Pathway in the Heart Subjected to Ischemia/reperfusion Injury
    He, Huamei
    Xiong, Hui
    McGowan, Francis X.
    CIRCULATION, 2019, 140
  • [8] p66Shc signaling does not contribute to tubular damage induced by renal ischemia-reperfusion injury in rat
    Miller, Bradley
    Regner, Kevin
    Sorokin, Andrey
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 603 : 69 - 74
  • [9] Post-ischemic in vivo p66shc silencing as a therapeutical strategy for ischemia/reperfusion brain injury
    Spescha, R. D.
    Klohs, J.
    Giacalone, G.
    Keller, S.
    Kaufmann, M.
    Wenger, R.
    Vogel, J.
    Sessa, M.
    Luscher, T. F.
    Camici, G. G.
    EUROPEAN HEART JOURNAL, 2013, 34 : 339 - 339
  • [10] REGγ deficiency ameliorates hepatic ischemia and reperfusion injury in a mitochondrial p66shc dependent manner in mice
    Guo, Long
    Yang, Qing
    Zhu, Jiali
    Li, Jinbao
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 9